我国辅助用药应用现状及管理对策初探

The Application Status of Adjuvant Drugs in Our Country and the Management Countermeasures Study

目的了解我国辅助用药的应用现状,初步探索辅助用药的管理措施。方法通过查阅文献及相关资料,总结归纳我国辅助用药的应用现状及全球合理化用药需求,通过德尔菲法设计调查问卷,对全国范围内的药学专家有关辅助用药相关内容进行3轮调查,初步探索辅助用药管理措施。结果调查中98%的医疗机构中存在辅助用药使用不合理/不规范的情况,药学专家认为如中药注射剂、肿瘤患者化疗以外的药物等都存在不合理使用情况,应该由国家对辅助用药的应用进行统一管理。结论我国过度使用辅助用药情况普遍,应设定辅助用药重点监测品种目录并进行应用评价,限定辅助用药使用指标,定期由专项点评小组对辅助用药的使用进行点评,以期规范辅助用药的临床应用。

OBJECTIVE To know the current application status of the adjuvant drugs in our country,and preliminary explore the management measures of adjuvant drugs. METHODS Through searching,reading,and summarizing the relevant content and literature,the application status of adjuvant drugs in China and the global demand for rationalization of drug use were reviewed. A few questionnaires that associated with adjuvant drugs were designed by Delphi method to investigate the medicine experts nationwide and to explore the management countermeasures of adjuvant drugs. RESULTS The survey showed that 98% of medical institutions existing adjuvant drugs use of unreasonable / no specification. The medicine experts believe that there are unreasonable usages such as traditional Chinese medicine injections,cancer drugs except for chemotherapy drugs,etc. The unified management of adjuvant drugs application should determined by the state. CONCLUSION The excessive use of adjuvant drugs ubiquitous in our country. Key monitoring varieties directory of adjuvant drugs and the limit to the drugs＇ use indicators to evaluate the rationality of drug use should be set. And there can be a special review team to review the use of adjuvant at regular intervals in order to standardize the clinical application of adjuvant drugs.